Literature DB >> 8345820

Body composition in children and Tanner's stages: a study with dual-energy x-ray absorptiometry.

H Rico1, M Revilla, L F Villa, E R Hernández, M Alvarez de Buergo, M Villa.   

Abstract

Total body bone mineral content (TBBM), body fat content (BF), and fat-free mass (FFM) were measured in 154 children using dual-energy x-ray absorptiometry (DEXA). Total body calcium level (TBCa) was calculated from TBBM. Children were divided into groups according to Tanner's stages 1, 2, 4, and 5. Children in stage 3 were not included in the study in order to better differentiate between prepubertal and postpubertal individuals. We did not find differences in TBBM, TBCa, BF, and FFM between Tanner's stages 1 and 2 or between sexes. TBBM and TBCa in stages 4 and 5 were lower in girls than in boys (P < .001 and P < .01, respectively); no differences were observed between girls of both groups, although boys showed significant differences (P < .05). FFM for both sexes was lower in stages 1 and 2 than in stages 4 and 5. Girls showed lower FFM (P < .001) than boys in stages 4 and 5; FFM was higher in boys in stage 5 than in those in stage 4 (P < .005), and the same was true for girls (P < .002). Boys in stage 4 had less BF than girls (P < .005), and the same was true for stage 5 (P < .001). Girls in stages 4 and 5 had greater BF than those in stages 1 and 2 (P < .001). These differences suggest that as boys go through puberty, both TBBM and FFM continue to increase, while in girls only BF and FFM increase. These data indicate clear sex differences in somatic postpubertal development.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8345820     DOI: 10.1016/0026-0495(93)90008-c

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  9 in total

1.  Contribution of androgens to the gender difference in leptin production in obese children and adolescents.

Authors:  M Wabitsch; W F Blum; R Muche; M Braun; F Hube; W Rascher; E Heinze; W Teller; H Hauner
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Hologic QDR 2000 whole-body scans: a comparison of three combinations of scan modes and analysis software.

Authors:  E Spector; A LeBlanc; L Shackelford
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

3.  Serum leptin levels in males with delayed puberty during short-term pulsatile GnRH administration.

Authors:  M Giusti; R Guido; S Valenti; G Giordano
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

4.  Body mass index and body composition measures by dual x-ray absorptiometry in patients aged 10 to 21 years with spinal cord injury.

Authors:  Craig M McDonald; Allison L Abresch-Meyer; Mindy Dopler Nelson; Lana M Widman
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

5.  Visceral adiposity would be expected to predict incident diabetes better in women than men.

Authors:  C M Schooling; C Q Jiang; W S Zhang; T H Lam; K K Cheng; G M Leung
Journal:  Diabetologia       Date:  2009-11-24       Impact factor: 10.122

Review 6.  The two faces of growth: benefits and risks to bone integrity.

Authors:  A M Parfitt
Journal:  Osteoporos Int       Date:  1994-11       Impact factor: 4.507

7.  Sociodemographic associations of longitudinal adiposity in youth with type 1 diabetes.

Authors:  Anna R Kahkoska; Christina M Shay; Sarah C Couch; Jamie Crandell; Dana Dabelea; Evgenia Gourgari; Jean M Lawrence; Angela D Liese; Catherine Pihoker; Beth A Reboussin; Natalie The; Elizabeth J Mayer-Davis
Journal:  Pediatr Diabetes       Date:  2018-09-14       Impact factor: 3.409

Review 8.  Pediatric DXA: technique and interpretation.

Authors:  Larry A Binkovitz; Maria J Henwood
Journal:  Pediatr Radiol       Date:  2006-05-20

9.  Weight Outcomes of Latino Adults and Children Participating in the Y Living Program, a Family-Focused Lifestyle Intervention, San Antonio, 2012-2013.

Authors:  Deborah Parra-Medina; Yuanyuan Liang; Zenong Yin; Laura Esparza; Louis Lopez
Journal:  Prev Chronic Dis       Date:  2015-12-10       Impact factor: 2.830

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.